Overview

The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar Treatment of Fractional CO2 Laser

Status:
Recruiting

Trial end date:
2024-12-31

Target enrollment:
0

Participant gender:
All

Summary

The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar Treatment of Fractional CO2 Laser

Phase:

Phase 4

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Xijing Hospital

Treatments:

Dezocine
Lidocaine

Criteria

Inclusion Criteria:

1. Age: 18-60 years old, regardless of gender;

2. Clinical diagnosis of atrophic acne scars;

3. Planning to undergo ultra-pulsed CO2 lattice laser therapy;

4. The patient agrees to participate in this experiment and signs an informed consent
form

Exclusion Criteria:

1. Those who take sedative drugs for a long time;

2. Patients with sleep apnea syndrome, previous history of hypertension, and blood
pressure greater than 160/100mmHg

3. People with severe heart and lung diseases, liver and kidney diseases, psychosis,
pregnancy, and communication disorders;

4. Persons who are known to be allergic to the main drug or any of the excipients in
Dezocine injection;

5. Increased intracranial pressure or head injury;

6. Acute and chronic alcoholism;

7. People with hypotension, hypothyroidism, acute episodes of asthma, and epilepsy

-